Algeta ASA Company Profile, Contacts & Intelligence
Algeta ASA Overview
March 6th The Bayer Group completed the voluntary takeover offer for Norwegian pharmaceutical company Algeta ASA, Oslo. As a result, Bayer now holds 98.2 % of the shares and voting rights in Algeta. Bayer intends to initiate a compulsory acquisition process in order to acquire the remaining shares of minority shareholders in Algeta in the coming days. Bayer intends to file for delisting of the Algeta shares from the Oslo Stock Exchange (OSE). Algeta is a company focused on developing, manufacturing and marketing novel targeted therapies for patients with cancer. Algeta's lead product Xofigo® injection (radium Ra 223 dichloride, radium-223; previously called Alpharadin) is an alpha particle-emitting pharmaceutical with an anti-tumor effect on bone metastases. In September 2009, Algeta signed an agreement with Bayer for the development and commercialization of Xofigo. Under the terms of this agreement, Bayer will develop, apply for health authority approvals worldwide and commercialize Xofigo globally. Algeta is eligible for royalties and milestones based on Bayer’s sales of Xofigo outside the US, and Algeta US is co-promoting Xofigo with Bayer in the US. Algeta is also evaluating the potential of Targeted Thorium Conjugates (TTCs), which are based on conjugating the alpha-emitter thorium-227 to targeting molecules, as a basis of a potential future pipeline of tumor-targeting alpha-pharmaceutical candidates. In December 2013, the Board of Directors of Algeta ASA announced that it had unanimously recommended the voluntary cash offer (the “Offer”) of NOK 362 per share from Bayer to acquire the entire issued share capital of Algeta.
- Headquarters
- Oslo, No
- Website
- algeta.com
- Industry
- Pharmaceutical Manufacturing
- Founded
- 1997
- NAICS
- Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing
- Phone Number
- Available in AeroLeads
- Company Email
- Available in AeroLeads
Algeta ASA Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Algeta ASA People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Algeta ASA Workforce Composition
Seniority breakdown across 15 visible profiles.
Algeta ASA Technology & Talent
Technology-related job titles represented in the visible people data.
Compare Similar Companies to Algeta ASA
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Bayer | Chemical Manufacturing | 92.87K | View company |
| Blueprint Medicines | Biotechnology Research | 795 | View company |
| Clarity Pharmaceuticals | Biotechnology Research | 65 | View company |
| Vistin Pharma AS | Pharmaceutical Manufacturing | 55 | View company |
| Bayer Norge | Pharmaceutical Manufacturing | 48 | View company |
| Oncoinvent ASA | Biotechnology Research | 43 | View company |
| Circio Holding ASA | Biotechnology Research | 19 | View company |
| Thor Medical ASA | Biotechnology Research | 19 | View company |
| AlgiPharma AS | Biotechnology Research | 12 | View company |
| Bionor Holding AS | Biotechnology | 5 | View company |